Candel Therapeutics, Inc.
USD10.14
+0.57 (+5.96%)
CEO
Paul-Peter Tak
IPO Date
2021-07-27
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$9.75
Prev. Close
$9.57
Day Low
$9.68
Day High
$10.29
52W Low
$4.35
52W High
$11.36
Market Cap
$0.56B
Volume
0.72M
| $0.00 |
| 1 Jul 2026 | Barone Francesca | Chief Scientific Officer | S-Sale | Disposed | 23,447 | $10.06 |
| 1 Jul 2026 | Tyagarajan Seshu | Chief Technology Officer | S-Sale | Disposed | 7,000 | $10.02 |
| 1 Jul 2026 | Manning Paul B | director | A-Award | Acquired | 2,199 | $10.30 |
| 1 Jul 2026 | PAPA JOSEPH C | director | A-Award | Acquired | 1,331 | $10.30 |
| 1 Jul 2026 | Loggia Nicoletta | director | A-Award | Acquired | 381 | $10.30 |
| 24 Jun 2026 | Radhakrishnan Maha | director | A-Award | Acquired | 32,000 | $9.08 |
| 24 Jun 2026 | Loggia Nicoletta | director | A-Award | Acquired | 32,000 | $9.08 |
| 24 Jun 2026 | PAPA JOSEPH C | director | A-Award | Acquired | 32,000 | $9.08 |